Valeant Pharmaceuticals North America LLC is categorized under in Bridgewater, NJ and active since 2010.
Valeant Pharmaceuticals North America LLC was established in 2010, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact J Michael Pearson at the company’s headquarters by writing to 700 Rte 202 206n, Bridgewater, New Jersey NJ 08807 or by phoning (908) 927-1400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Valeant Pharmaceuticals North America LLC |
| Contact Person: | J Michael Pearson |
| Address: | 700 Rte 202 206n, Bridgewater, New Jersey 08807 |
| Phone Number: | (908) 927-1400 |
| Website Address: | valeant.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2010 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 325412 |
| Share This Business: |
Valeant Pharmaceuticals North America LLC was started in 2010 to provide professional under the SIC code 2834 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact J Michael Pearson for inquiries that concern Valeant Pharmaceuticals North America LLC by calling the company number (908) 927-1400, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Valeant Pharmaceuticals North America LLC can be found at the coordinates 40.574807,-74.658649 as well as the street address 700 Rte 202 206n in Bridgewater, New Jersey 08807.
For its online presence, you may visit Valeant Pharmaceuticals North America LLC’s website at valeant.com and engage with its social media outlets through on Twitter and on Facebook.